Bhaumik Patel

Bhaumik Patel has a diverse work experience in the pharmaceutical industry spanning over many years. Bhaumik currently holds the position of Director of New Technology at CURE Pharmaceutical, where they are responsible for product innovations and managing the entire product development cycle. Prior to this, they worked as a Senior Scientist Group Lead at Chemistry Holdings Inc., where they contributed to the development of oral delivery systems and identified new technologies to enhance the delivery system portfolio. Before that, they served as a Scientist in Technical Services at Lannett Company, where they led various projects related to product/process technology transfer and improvement. Bhaumik also worked as a Formulation Scientist at Sancilio & Company, where they developed fill formulations for the soft gel dosage form. Earlier in their career, they worked as a Microencapsulation Scientist/ Project Manager at Vision Processing Technologies, Inc. and as a Research Assistant at Long Island University. Bhaumik also gained experience as a Formulation & Technology Development Scientist at Elite Pharma, where they were involved in various activities related to new technology development and the development of generic pharmaceutical products.

Bhaumik Patel's education history begins in 2002 when they enrolled at A.R.COLLEGE OF PHARMACY & G.H.P. INSTITUTE OF PHARMACY, V.V.NAGAR (GIA) 201 for their Bachelor of Pharmacy (B.Pharm.) degree, which they completed in 2006. Following this, they attended Long Island University from 2007 to 2009 and obtained a Master of Science (M.S.) degree in Industrial Pharmacy.

In 2019, Bhaumik Patel continued their education at the Massachusetts Institute of Technology (MIT) by joining the Technology Leadership Program. Bhaumik completed this program in 2020 but did not specify the field of study for this degree.

Furthermore, in November 2021, Bhaumik Patel obtained a certification in the Technology Leadership Program from MIT Professional Education.